Study of avacopan as part of an Early Access program in Spain
Latest Information Update: 13 Jan 2024
At a glance
- Drugs Avacopan (Primary)
- Indications Anti-neutrophil cytoplasmic antibody-associated vasculitis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 13 Jan 2024 New trial record
- 15 Nov 2023 Results presented at the ACR Convergence 2023